Image
20.06.2023
Shining a light on diabetes tech in the south west and south central r...
As part of our Diabetes Week activity, we hosted a webinar for our local diabetes community to highlight ...
customer support
customer support
From research findings supporting SGLT-2 inhibitors as a first-choice type 2 treatment to a real-world study strengthening evidence for teplizumab in early type 1, here are some of the diabetes research developments announced in February 2026.
Read more